Related Experiment Video
Updated: Jul 16, 2026

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
Probiotics may alleviate intestinal damage induced by cardiopulmonary bypass in children
Daisuke Toritsuka1, Masaya Aoki1, Akihiko Higashida2
1Department of Cardiovascular Surgery, Graduate School of Medicine, University of Toyama, Toyama, Japan.
Insights
Probiotics corrected gut dysbiosis after cardiopulmonary bypass but did not prevent intestinal damage. Further research is needed for effective interventions against cardiac surgery-induced gut disturbances.
Area of Science:
- Gastroenterology
- Cardiology
- Microbiology
Background:
- Cardiopulmonary bypass (CPB) can induce intestinal ischemia-reperfusion injury, leading to barrier dysfunction, dysbiosis, and bacterial translocation.
- Understanding these effects is crucial for managing patients undergoing cardiac surgery.
Purpose of the Study:
- To investigate epithelial barrier dysfunction and bacterial translocation following CPB.
- To assess the impact of probiotics on CPB-induced gut microbiota changes and related conditions.
Main Methods:
- A randomized prospective study involving 82 pediatric patients (0-15 years) undergoing cardiac surgery with CPB.
- Patients were allocated to receive probiotics (intervention) or no probiotics (control).
- Analysis included fecal and blood microbiota, organic acids, intestinal fatty acid-binding protein, and immunological responses.
Main Results:
- Probiotics increased obligate anaerobes and corrected dysbiosis post-CPB (after day 7).
- No significant differences were observed between groups in bacterial translocation, intestinal damage markers (intestinal fatty acid-binding protein), or most immunological responses.
- Probiotics did not sufficiently alleviate intestinal damage induced by CPB.
Conclusions:
- Probiotics can modulate the gut microbiota towards a less dysbiotic state after CPB.
- Current probiotic administration is insufficient to prevent or mitigate CPB-induced intestinal damage.
- Novel strategies are required to prevent gut disturbances associated with cardiac surgery and CPB.
Objectives:
Intestinal ischaemia-reperfusion injury induced by cardiopulmonary bypass causes intestinal epithelial barrier dysfunction, leading to dysbiosis and bacterial translocation. We conducted a randomized prospective study with 2 objectives: (i) to investigate epithelial barrier dysfunction and bacterial translocation induced by cardiopulmonary bypass and changes in the gut microbiota and (ii) to verify whether probiotics can improve these conditions.
Methods:
Between 2019 and 2020, patients 0-15 years old scheduled to undergo cardiac surgery using cardiopulmonary bypass were enrolled and randomly allocated to 2 groups: the intervention group received probiotics and the control group did not receive probiotics. We analysed the microbiota in faeces and blood, organic acid concentrations in faeces, plasma intestinal fatty acid-binding protein and immunological responses.
Results:
Eighty-two patients were enrolled in this study. The characteristics of the patients were similar in both groups. The total number of obligate anaerobes was higher in the intervention group than in the control group after postoperative day 7. We identified 4 clusters within the perioperative gut microbiota, and cluster changes showed a corrective effect of probiotics on dysbiosis after postoperative day 7. Organic acid concentrations in faeces, incidence of bacterial translocation, intestinal fatty acid-binding protein levels and immunological responses, except for interleukin -17A, were not markedly different between the 2 groups.
Conclusions:
Administration of probiotics was able to correct dysbiosis but did not sufficiently alleviate the intestinal damage induced by cardiopulmonary bypass. More effective methods should be examined to prevent disturbances induced by cardiac surgery using cardiopulmonary bypass.
Clinical Trial Registration Number:
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037174 UMIN000035556.
Related Concept Videos
Probiotics
Development of Human Microbiota
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics

